{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:51:13Z","timestamp":1790844673035,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Primary Care: Clinics in Office Practice"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.pop.2011.05.001","type":"journal-article","created":{"date-parts":[[2011,8,27]],"date-time":"2011-08-27T13:35:55Z","timestamp":1314452155000},"page":"383-394","source":"Crossref","is-referenced-by-count":94,"title":["Peptic Ulcer Disease"],"prefix":"10.1016","volume":"38","author":[{"given":"Wadie I.","family":"Najm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.pop.2011.05.001_bib1","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/aje\/kwj129","article-title":"Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study","volume":"163","author":"Aro","year":"2006","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.pop.2011.05.001_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10620-008-0708-x","article-title":"Risk factors for gastrointestinal ulcer disease in the US population","volume":"55","author":"Garrow","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.pop.2011.05.001_bib3","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2036.2009.03960.x","article-title":"Systematic review: the global incidence and prevalence of peptic ulcer disease","volume":"29","author":"Sung","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.pop.2011.05.001_bib4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/CMR.00054-05","article-title":"Pathogenesis of Helicobacter pylori Infection","volume":"19","author":"Kusters","year":"2006","journal-title":"Clinical Microbilology Reviews"},{"issue":"7","key":"10.1016\/j.pop.2011.05.001_bib5","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1053\/j.gastro.2007.03.108","article-title":"Time trends of ulcer mortality in Europe","volume":"132","author":"Sonnenberg","year":"2007","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.pop.2011.05.001_bib6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1754-4505.2007.tb00334.x","article-title":"Heficobacter pyfori infection in people who are intellectually and developmentally disabled: a review","volume":"27","author":"Kitchens","year":"2007","journal-title":"Spec Care Dentist"},{"issue":"12","key":"10.1016\/j.pop.2011.05.001_bib7","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1365-2036.2007.03340.x","article-title":"Decreasing prevalence combined with increasing eradication of Helicobacter pylori infection in the United States has not resulted in fewer hospital admissions for peptic ulcer disease-related complications","volume":"25","author":"Manuel","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.pop.2011.05.001_bib8","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1365-2036.2006.02918.x","article-title":"Declining incidence of peptic ulcer but not of its complications: a nationwide study in The Netherlands","volume":"23","author":"Post","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.pop.2011.05.001_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2036.2006.02960.x","article-title":"Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland 1982\u20132002","volume":"24","author":"Kang","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.pop.2011.05.001_bib10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/MCG.0b013e318030e3c3","article-title":"Helicobacter pylori infection and related gastrointestinal diseases","volume":"41","author":"Makola","year":"2007","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"40","key":"10.1016\/j.pop.2011.05.001_bib11","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.3748\/wjg.v12.i40.6413","article-title":"Precise role of H pylori in duodenal ulceration","volume":"12","author":"Hobsley","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.pop.2011.05.001_bib12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jbspin.2009.11.008","article-title":"Preventing the gastrointestinal adverse effects of nonsteroidal anti-inflammatory drugs: from risk factor identification to risk factor intervention","volume":"77","author":"Bardou","year":"2010","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.pop.2011.05.001_bib13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/ard.2006.055012","article-title":"The rate of NSAID-induced endoscopic ulcers increases linearly but not exponentially with age: a pooled analysis of 12 randomised trials","volume":"66","author":"Boers","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.pop.2011.05.001_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00002018-200831020-00004","article-title":"Evaluation of risk profiles for gastrointestinal and cardiovascular adverse effects in nonselective NSAID and COX-2 inhibitor users: a cohort study using pharmacy dispensing data in The Netherlands","volume":"31","author":"Layton","year":"2008","journal-title":"Drug Saf"},{"issue":"7472","key":"10.1016\/j.pop.2011.05.001_bib15","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/bmj.38232.680567.EB","article-title":"The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review","volume":"329","author":"Hooper","year":"2004","journal-title":"BMJ"},{"issue":"9560","key":"10.1016\/j.pop.2011.05.001_bib16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0140-6736(07)60234-7","article-title":"Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programm: a randomised comparison","volume":"369","author":"Laine","year":"2007","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.pop.2011.05.001_bib17","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/j.1365-2036.2006.02912.x","article-title":"The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective nonsteroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor","volume":"23","author":"Goldstein","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.pop.2011.05.001_bib18","first-page":"1005","article-title":"Peptic ulcer disease","volume":"76","author":"Ramakrishnan","year":"2007","journal-title":"Am Fam Physician"},{"issue":"4","key":"10.1016\/j.pop.2011.05.001_bib19","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.amjmed.2009.09.031","article-title":"Systematic review of the symptom burden, quality-of-life impairment, and costs associated with peptic ulcer disease","volume":"123","author":"Barkun","year":"2010","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.pop.2011.05.001_bib20","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1572-0241.2001.03455.x","article-title":"Absence of abdominal pain in older persons with endoscopic ulcers: a prospective study","volume":"96","author":"Hilton","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.pop.2011.05.001_bib21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0016-5107(04)01311-2","article-title":"Silent peptic ulcer disease: frequency, factors leading to silence, and implications regarding the pathogenesis of visceral symptoms","volume":"60","author":"Lu","year":"2004","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"10.1016\/j.pop.2011.05.001_bib22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/ncpgasthep0393","article-title":"Peptic ulcer disease today","volume":"3","author":"Yuan","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.pop.2011.05.001_bib23","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.bpg.2009.10.004","article-title":"Acid-related disorders in the elderly","volume":"23","author":"Franceschi","year":"2009","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.pop.2011.05.001_bib24","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1532-5415.2010.02826.x","article-title":"Prognosis of upper gastrointestinal bleeding in the oldest-old patients: a post hoc analysis of a prospective study","volume":"58","author":"Nahon","year":"2010","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.pop.2011.05.001_bib25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/ajg.2009.507","article-title":"Causes of mortality in patients with peptic ulcer bleeding: a prospective cohort study of 10,428 cases","volume":"105","author":"Sung","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.pop.2011.05.001_bib26","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/ajg.2010.115","article-title":"Causes of mortality related to peptic ulcer bleeding in a prospective cohort of 965 French patients: a plea for primary prevention","volume":"105","author":"Nahon","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.pop.2011.05.001_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cgh.2008.08.016","article-title":"Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials","volume":"7","author":"Laine","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.pop.2011.05.001_bib28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncpgasthep0388","article-title":"Current management of peptic ulcer bleeding","volume":"3","author":"Sung","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.pop.2011.05.001_bib29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.gtc.2009.03.003","article-title":"Management of massive peptic ulcer bleeding","volume":"38","author":"Cheung","year":"2009","journal-title":"Gastroenterol Clin North Am"},{"issue":"10","key":"10.1016\/j.pop.2011.05.001_bib30","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJM199903113401002","article-title":"Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers","volume":"340","author":"Lau","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.pop.2011.05.001_bib31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s002689910045","article-title":"Trends in perforated peptic ulcer: incidence, etiology, treatment, and prognosis","volume":"24","author":"Svanes","year":"2000","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.pop.2011.05.001_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00000658-200002000-00001","article-title":"Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation: randomized controlled trial","volume":"231","author":"Ng","year":"2000","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.pop.2011.05.001_bib33","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1007\/s00268-008-9707-5","article-title":"Comparison between open and laparoscopic repair of perforated peptic ulcer disease","volume":"32","author":"Bhogal","year":"2008","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.pop.2011.05.001_bib34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00000658-198701000-00005","article-title":"Risk stratification in perforated duodenal ulcers. A prospective validation of predictive factors","volume":"205","author":"Boey","year":"1987","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.pop.2011.05.001_bib35","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1001\/archsurg.133.11.1166","article-title":"Perforated duodenal ulcer: an alternative therapeutic plan","volume":"133","author":"Donovan","year":"1998","journal-title":"Arch Surg"},{"issue":"10","key":"10.1016\/j.pop.2011.05.001_bib36","first-page":"1769","article-title":"Malignancy is the most common cause of gastric outlet obstruction in the era of H2 blockers","volume":"90","author":"Shone","year":"1995","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.pop.2011.05.001_bib37","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00000658-198502000-00007","article-title":"The prognosis of gastric outlet obstruction","volume":"201","author":"Jaffin","year":"1985","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.pop.2011.05.001_bib38","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0016-5107(90)71163-7","article-title":"Long-term follow-up in patients who have undergone balloon dilation for gastric outlet obstruction","volume":"36","author":"Kozarek","year":"1990","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"10.1016\/j.pop.2011.05.001_bib39","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/01.mog.0000239874.13867.41","article-title":"Endoscopic therapy of benign pyloric stenosis and gastric outlet obstruction","volume":"22","author":"Yusuf","year":"2006","journal-title":"Curr Opin Gastroenterol"},{"issue":"38","key":"10.1016\/j.pop.2011.05.001_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta10380","article-title":"A\u00a0comparison of the cost-effectiveness of five strategies for the prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling","volume":"10","author":"Brown","year":"2006","journal-title":"Health Technol Assess"},{"issue":"1","key":"10.1016\/j.pop.2011.05.001_bib41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2165\/00003495-200969010-00004","article-title":"Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors","volume":"69","author":"Lazzaroni","year":"2009","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.pop.2011.05.001_bib42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1185\/030079907X162656","article-title":"Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment","volume":"23","author":"Lanas","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.pop.2011.05.001_bib43","unstructured":"Helicobacter pylori and peptic ulcer disease. The key to cure. Available at: http:\/\/www.cdc.gov\/ulcer\/keytocure.htm#treatment. Accessed June 20, 2011."},{"issue":"6","key":"10.1016\/j.pop.2011.05.001_bib44","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gut.2006.101634","article-title":"Current concepts in the management of Helicobacter pylori infection: the Maastricht III consensus report","volume":"56","author":"Malfertheiner","year":"2007","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.pop.2011.05.001_bib45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/ajg.2009.508","article-title":"Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: systematic review and meta-analysis of efficacy and tolerability","volume":"105","author":"Luther","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.pop.2011.05.001_bib46","doi-asserted-by":"crossref","first-page":"923","DOI":"10.7326\/0003-4819-148-12-200806170-00226","article-title":"Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment","volume":"148","author":"Jafri","year":"2008","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.pop.2011.05.001_bib47","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pop.2010.02.003","article-title":"Integrative medicine and gastrointestinal disease","volume":"37","author":"Michelfelder","year":"2010","journal-title":"Prim Care"},{"issue":"1","key":"10.1016\/j.pop.2011.05.001_bib48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1651-2227.2008.00977.x","article-title":"A\u00a0randomized open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children","volume":"98","author":"Hurduc","year":"2009","journal-title":"Acta Paediatr"},{"issue":"7","key":"10.1016\/j.pop.2011.05.001_bib49","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1365-2036.2009.03934.x","article-title":"Meta-analysis: efficacy of bovine lactoferrin in Helicobacter pylori eradication","volume":"29","author":"Sachdeva","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.pop.2011.05.001_bib50","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1572-0241.2007.01085.x","article-title":"Helicobacter pylori eradication: a randomized prospective study of triple therapy plus lactoferrin and probiotics","volume":"102","author":"de Bortoli","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.pop.2011.05.001_bib51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/MEG.0b013e32830d0eff","article-title":"Effect of fermented milk-based probiotic preparations on Helicobacter pylori eradication: a systematic review and meta-analysis of randomized\u2013controlled trials","volume":"21","author":"Sachdeva","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Primary Care: Clinics in Office Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454311000388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454311000388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T13:24:57Z","timestamp":1543584297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095454311000388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0095454311000388"],"URL":"https:\/\/doi.org\/10.1016\/j.pop.2011.05.001","relation":{},"ISSN":["0095-4543"],"issn-type":[{"value":"0095-4543","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}